Levosimendan in Liver Transplant

The concentration of levosimendan, OR-1855, and...

Molecular Targets and Pharmacological Effects o...

Pharmacodynamics of the levosimendan. | Downloa...

(PDF) The Use of Levosimendan in Patients Under...

Effects of levosimendan on liver histopathology...

(PDF) Levosimendan: A Cardiovascular Drug to Pr...

Hepatic microcirculation after ‘‘early’’ levosi...

Effects of levosimendan on cell viability in he...

Figure 2 from The histopathological effects of ...

(PDF) Outpatient 6-Hour Levosimendan Treatment ...

Figure 1 from The histopathological effects of ...

Figure 1 from Levosimendan: beyond its simple i...

(PDF) Levosimendan In Cardiology and Cardiac Su...

(PDF) [Pilot study of levosimendan : Effect on ...

Levosimendan for Haemodynamic Support after Car...

(PDF) Levosimendan in lung transplant recipient...

Effects of levosimendan on liver histopathology...

Figure 1 from Therapeutic Development of Levosi...

Effects of levosimendan on cell survival signal...

Survival until day 7 after levosimendan adminis...

Schematic illustration of the mechanisms by whi...

Survival until day 7 after levosimendan adminis...

Long presentation on mechanism of action of lev...

Levosimendan : WFSA - Resources

Effects of levosimendan on liver histopathology...

(PDF) Levosimendan in Acute and Advanced Heart ...

Effects of levosimendan on nitric oxide release...

(PDF) Levosimendan in lung transplant recipient...

Outpatient 6-Hour Levosimendan Treatment as a B...

Long presentation on mechanism of action of lev...

Long presentation on mechanism of action of lev...

Long presentation on mechanism of action of lev...

(PDF) Inhaled Levosimendan versus Intravenous L...

Scheme of the putative selective effect of levo...

Figure 1 from Levosimendan: beyond its simple i...